Ascentage Pharma Group International - Bathi mangsa ngarep AAPG

AAPG (Ascentage Pharma Group International) - tandha merek perusahaan

Ascentage Pharma Group (AAPG) complies with medical regulations regarding the disposal of biomaterials. The development of cancer therapies relies on AI modeling and automated substance synthesis under physician supervision. High-tech robots accelerate the bioscreening of compounds. This forward earnings chart visualizes these processes, where 0.03 becomes the new metric value, helping to assess the asset's future cash flows.

AAPG: Bathi mangsa ngarep ascentage.com 25.01.2025 - 28.11.2025

Ascentage - rincian analitis lan metrik utama (AAPG)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:ascentage.com, AAPG
Barang utama Ascentage Pharma Group International

This indicator calculates the expected financial return through probability distributions of future cash flows, determining the fundamental value of the business based on projected revenues. Amid FDA pressure and the US-China trade confrontation, the risk of asset freezes for Ascentage Pharma Group (AAPG) directly impacts target profit metrics, where the stability of the curve may mask hidden opportunity costs.

Pesaing utama

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|CGON (CG Oncology Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep URGN (urogen.com)|BCAX - Bathi mangsa ngarep|PSNL: Bathi mangsa ngarep|ERAS - Proyeksi bathi mangsa ngarep|Delcath (DCTH) - Bathi sing dikarepake|YmAbs - Penghasilan resik sing dikarepake|AURA (Aura Biosciences Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Candel Therapeutics CADL|Proyeksi bathi mangsa ngarep ARAY|SLS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ACTU (Actuate Therapeutics Inc)|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake